用于早期检测和治疗心力衰竭的预测生物标志物
Vignesh Mariappan1, Rajesh Srinivasan1, Ravindran Pratheesh2
1Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, 607402, India.
Heart failure reviews
|September 13, 2023
概括
识别循环生物标志物对于早期发现和治疗心力衰竭 (HF) 至关重要,这是一个日益严重的公共卫生问题. 本综述探讨了omics平台和生物标志物,包括与内皮生物学相关的生物标志物,以改善HF预测和个性化治疗策略.
科学领域:
- 生物分子科学 生物分子科学
- 心血管研究研究心血管研究
- 公共卫生 公共卫生
背景情况:
- 心血管疾病 (CVD) 是一个不断增长的全球健康问题,心力衰竭 (HF) 预计是导致死亡的主要原因.
- 肝炎是一种复杂的综合症,原因和病理生理学各异,涉及炎症,亡,纤维化和神经幽默路径.
- 在HF进展期间释放的循环生物分子可以表明亚临床变化和疾病严重程度.
研究的目的:
- 为发现心力衰竭生物标志物提供omics平台的全面概述.
- 讨论早期HF检测的现有和新型生物标志物,强调内皮细胞生物学.
- 突出识别生物标志物对于早期预测和个性化高频管理的重要性.
主要方法:
- 审查当前的omics技术用于心力衰竭中的生物标志物发现.
- 对HF的既定和新兴生物标志物的文献分析.
- 专注于与内皮功能和心血管健康相关的生物标志物.
主要成果:
- 奥米克斯平台提供了强大的工具,用于识别新的心力衰竭生物标志物.
- 几种循环中的生物分子显示出早期HF检测和监测的潜力.
- 与内皮细胞生物学相关的标志物对理解HF病变发生和进展具有重要意义.
结论:
- 早期识别循环生物标志物对于预测和管理心力衰竭至关重要.
- 多生物标志物策略和奥米克方法可以为HF患者提供个性化治疗策略.
- 进一步研究新型生物标志物,特别是与内皮功能相关的生物标志物,对于推进HF护理至关重要.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
118
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
118
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
200
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
200
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


